Montana LTBI Report Form

• This form is used to report cases of LTBI from your local health department to the state health department. If you have questions about reporting a case of LTBI, contact your local health department.

MTDPHHS Summary of ARM Changes 2019

• Summary of ARM changes and where the changes are located within rule.

LTBI Introduction Letter

• This letter can be used to introduce providers or other individuals to the recent rule change making LTBI reportable.

LTBI Frequently Asked Questions (FAQs)

• This document contains answers to some of the most frequently asked questions regarding LTBI and this toolkit.

LTBI Testing Flowchart

• Guide for what steps should be followed and what tests to order when confirming a LTBI case and excluding active disease.

LTBI Pediatric Guidelines

• This guide is intended for primary health care providers to use in the management of latent TB infection in children and adolescents. This is the Addendum to this document which contains the latest treatment options for this age group.

LTBI Treatment Guide for Primary Health Care Providers

• This guide is intended for primary health care providers to use in testing and treating those with latent TB infection. It also contains information on dosing, adverse drug effects, patient monitoring, and special considerations in treatment of LTBI.

Updated LTBI Treatment Guidelines 2020

• This is updated guidance for LTBI treatment regimens. The guidance strengthens the evidence for use of short course regimens, and introduces another regimen for provider consideration.

Montana Adult TB Risk Assessment Form

• Use this tool to identify asymptomatic adults for latent TB infection (LTBI) testing.

Provider Guidance Isoniazid and Rifapentine NTCA

• Helpful 2-page guidance on the 12-week regimen. Contains dosing, adverse events, and monitoring suggestions.

TB 101 for Health Care Workers

• Web-based course that offers continuing education free of charge. It is designed to educate health care workers about basic concepts related to TB prevention and control in the U.S.

Patient Info Isoniazid and Rifapentine-specific Regimen

• What your patient needs to know about the 12-week regimen. Includes strategies to best take their medication, adverse effects of meds to be aware of, and a schedule for the patient.

Patient Info Rifampin-specific Regimen

• What your patient needs to know about the 4-month rifampin regimen. Includes strategies to best take their medication, adverse effects of meds to be aware of, and a schedule for the patient.

Patient Info Isoniazid-specific Regimen

• What your patient needs to know about the 9-month isoniazid regimen. Includes strategies to best take their medication, adverse effects of meds to be aware of, and a schedule for the patient.

Tuberculin Skin Testing (TST) Fact Sheet

• Basic information on the TST including cut points, how it’s read, and administered.

Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection Fact Sheet

• Basic information on IGRAs including when to use them, differences in currently available IGRAs, and advantages/disadvantages.

The Difference Between Latent TB Infection and TB Disease Fact Sheet

• Basic information on the difference between active TB disease and LTBI including which one is infectious, symptoms of concern, and descriptions of each.

TB Flipbook – Patient Education

• Helpful educational tool designed to be used in the presence of a patient. Materials can be printed off and bound to create a flipbook.

Patient Education Materials Series - Pamphlets, Brochures, Booklets - Publications & Products

• Helpful factsheets and information on TB in a variety of languages.

Find TB Resources

• This is a great resource hub where you can find resources from CDC and other states. You can also search by language if you have a patient whose primary language is not English.

TST in 3D

• This online TST/IGRA interpreter estimates the risk of active tuberculosis for an adult based on his/her reaction to a tuberculin skin test (TST) or Interferon Gamma Release Assay (IGRA) and clinical profile.

The BCG World Atlas

• Provides information on BCG policies and practice for over 180 countries to assist clinicians with interpretation of TB diagnostics.

USPSTF Final Recommendation Statement for Latent Tuberculosis Infection: Screening

• U.S. Preventive Services Task Force (USPSTF) recommends screening for TB infection in populations at increased risk.

TB Free California Resources for Providers

• Includes scripts of how to talk to patients about LTBI, a 3HP drug interactions guide, LTBI treatment cards, etc.